Alembic Pharma receives USFDA approval: Amlodipine + Atorvastatin Tablets.

Alembic Pharmaceuticals has received final #USFDA approval for its generic version of Amlodipine and Atorvastatin Tablets-a comb. drug for high blood pressure and high cholesterol.

🔸Drug approved:Amlodipine + Atorvastatin    Tablets

🔸Purpose:Treats hypertension and hyperlipidemia

🔸Reference drug (RLD):Caduet by Pharmacia & Upjohn

🔸Strengths approved: 11 combinations, from 2.5/10 mg to 10/80 mg

🔸USFDA status:Therapeutically equivalent to Caduet

🔸Total USFDA approvals for Alembic:223 ANDAS

Alembic Pharmaceuticals Limited continues to expand its #US footprint with solid R&D and regulatory track record.